Riskpilot← Back to searchSign inGet full accessDR. KJELL HARBO AS
ASActiveOrg 989439006Kronpr. Marthas Gate 17, 4044 HafrsfjordMedical specialists activities · NACE 8622Est. 20060 employees
Revenue 2023
NOK 0
EBITDA margin
—
+4% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
NOK 481K
+242% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -14K | +4% |
| Net profit | NOK 481K | +242% |
| Total assets | NOK 3,4M | +16% |
| Equity | NOK 3,4M | +16% |
| Employees | 0 | — |
Legal name
DR. KJELL HARBO AS
Org number
989439006
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
22. februar 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive henvisningspraksis i spesialiteten ortopedisk kirurgi, samt konsulentvirksomher. Generell medisinsk virskomhet. Investere i verdipapirer og annet
Address
Kronpr. Marthas Gate 17, 4044 Hafrsfjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −27 | −28 | −19 | −14 | −14 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −27 | −28 | −19 | −14 | −14 |
| Net financials | 715 | 144 | 443 | −325 | 495 |
| Profit before tax | 688 | 116 | 423 | −339 | 481 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 688 | 116 | 423 | −339 | 481 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 769 | 2 882 | 3 305 | 2 966 | 3 447 |
| Equity | 2 766 | 2 882 | 3 305 | 2 966 | 3 447 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 | 0 | 0 | 0 | 0 |
| Total debt | 3 | 0 | 0 | 0 | 0 |
EBITDA margin
-1361100.0%
This company
15.8%
Market median
-8614657% vs market
20192023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192023
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20192023
Net profit margin
48090300.0%
This company
8.1%
Market median
+593707307% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KH Chief Executive Officer | Chief Executive Officer | 2006 |
JM Deputy Member | Deputy Member | 2006 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15% | 15% | 2022 | |
| Individual | 15% | 15% | 2022 | |
| Individual | 15% | 15% | 2022 | |
| Individual | 15% | 15% | 2022 | |
| Individual | 15% | 15% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DR. KJELL HARBO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Harbo | Chief Executive Officer | 0 companies |
| Jette Marie Harbo | Deputy Member | 0 companies |